Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Aberrant MicroRNA Expression and Its Implications for Uveal Melanoma Metastasis.

Smit KN, Chang J, Derks K, Vaarwater J, Brands T, Verdijk RM, Wiemer EAC, Mensink HW, Pothof J, de Klein A, Kilic E.

Cancers (Basel). 2019 Jun 12;11(6). pii: E815. doi: 10.3390/cancers11060815.

2.

Reply.

van Poppelen NM, Vaarwater J, Mudhar HS, Sisley K, van den Bosch QCC, de Klein A, Kiliç E, Verdijk RM.

Ophthalmology. 2018 Nov;125(11):e79-e80. doi: 10.1016/j.ophtha.2018.05.022. No abstract available.

PMID:
30318045
3.

Chromosomal rearrangements in uveal melanoma: Chromothripsis.

van Poppelen NM, Yavuzyigitoglu S, Smit KN, Vaarwater J, Eussen B, Brands T, Paridaens D, Kiliç E, de Klein A.

Genes Chromosomes Cancer. 2018 Sep;57(9):452-458. doi: 10.1002/gcc.4. Epub 2018 Jul 30.

4.

Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential.

van Poppelen NM, Vaarwater J, Mudhar HS, Sisley K, Rennie IG, Rundle P, Brands T, van den Bosch QCC, Mensink HW, de Klein A, Kiliç E, Verdijk RM.

Ophthalmology. 2018 Jun;125(6):904-912. doi: 10.1016/j.ophtha.2017.12.022. Epub 2018 Jan 19.

5.

Combined mutation and copy-number variation detection by targeted next-generation sequencing in uveal melanoma.

Smit KN, van Poppelen NM, Vaarwater J, Verdijk R, van Marion R, Kalirai H, Coupland SE, Thornton S, Farquhar N, Dubbink HJ, Paridaens D, de Klein A, Kiliç E.

Mod Pathol. 2018 May;31(5):763-771. doi: 10.1038/modpathol.2017.187. Epub 2018 Jan 12.

6.

Correlation of Gene Mutation Status with Copy Number Profile in Uveal Melanoma.

Yavuzyigitoglu S, Drabarek W, Smit KN, van Poppelen N, Koopmans AE, Vaarwater J, Brands T, Eussen B, Dubbink HJ, van Riet J, van de Werken HJ, Beverloo B, Verdijk RM, Naus N, Paridaens D, Kilic E, de Klein A; Rotterdam Ocular Melanoma Study Group.

Ophthalmology. 2017 Apr;124(4):573-575. doi: 10.1016/j.ophtha.2016.10.039. Epub 2016 Dec 1. No abstract available.

PMID:
27916271
7.

Lipomatous Change in Uveal Melanoma: Histopathological, Immunohistochemical and Cytogenetic Analysis.

Yavuzyigitoglu S, Kilic E, Vaarwater J, de Klein A, Paridaens D, Verdijk RM; Rotterdam Ocular Melanoma Study Group (ROMS).

Ocul Oncol Pathol. 2016 Apr;2(3):133-5. doi: 10.1159/000440981. Epub 2015 Nov 20.

8.

Metastatic Disease in Polyploid Uveal Melanoma Patients Is Associated With BAP1 Mutations.

Yavuzyigitoglu S, Mensink HW, Smit KN, Vaarwater J, Verdijk RM, Beverloo B, Brüggenwirth HT, van Marion R, Dubbink HJ, Paridaens D, Naus NC, de Klein A, Kiliç E; Rotterdam Ocular Melanoma Study Group (ROMS).

Invest Ophthalmol Vis Sci. 2016 Apr 1;57(4):2232-9. doi: 10.1167/iovs.15-18608.

PMID:
27116551
9.

Uveal Melanomas with SF3B1 Mutations: A Distinct Subclass Associated with Late-Onset Metastases.

Yavuzyigitoglu S, Koopmans AE, Verdijk RM, Vaarwater J, Eussen B, van Bodegom A, Paridaens D, Kiliç E, de Klein A; Rotterdam Ocular Melanoma Study Group.

Ophthalmology. 2016 May;123(5):1118-28. doi: 10.1016/j.ophtha.2016.01.023. Epub 2016 Feb 26.

PMID:
26923342
10.

Metastatic disease in uveal melanoma: importance of a genetic profile?

Van Beek JG, Koopmans AE, Vaarwater J, Verdijk RM, de Klein A, Naus NC, Kiliç E.

Melanoma Res. 2015 Oct;25(5):447-9. doi: 10.1097/CMR.0000000000000176.

PMID:
26086698
11.

Risk factors associated with secondary enucleation after fractionated stereotactic radiotherapy in uveal melanoma.

van den Bosch T, Vaarwater J, Verdijk R, Muller K, Kiliç E, Paridaens D, de Klein A, Naus N.

Acta Ophthalmol. 2015 Sep;93(6):555-60. doi: 10.1111/aos.12731. Epub 2015 Apr 15.

12.

Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.

Koopmans AE, Ober K, Dubbink HJ, Paridaens D, Naus NC, Belunek S, Krist B, Post E, Zwarthoff EC, de Klein A, Verdijk RM; Rotterdam Ocular Melanoma Study Group.

Invest Ophthalmol Vis Sci. 2014 Aug 26;55(9):6024-30. doi: 10.1167/iovs.14-14901.

PMID:
25159205
13.

Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma.

Koopmans AE, Verdijk RM, Brouwer RW, van den Bosch TP, van den Berg MM, Vaarwater J, Kockx CE, Paridaens D, Naus NC, Nellist M, van IJcken WF, Kiliç E, de Klein A.

Mod Pathol. 2014 Oct;27(10):1321-30. doi: 10.1038/modpathol.2014.43. Epub 2014 Mar 14.

14.

The prognostic value of extraocular extension in relation to monosomy 3 and gain of chromosome 8q in uveal melanoma.

van Beek JG, Koopmans AE, Vaarwater J, de Rooi JJ, Paridaens D, Naus NC, de Klein A, Verdijk RM, Kiliç E.

Invest Ophthalmol Vis Sci. 2014 Mar 4;55(3):1284-91. doi: 10.1167/iovs.13-13670.

PMID:
24508790
15.

Chemokine receptor CCR7 expression predicts poor outcome in uveal melanoma and relates to liver metastasis whereas expression of CXCR4 is not of clinical relevance.

van den Bosch T, Koopmans AE, Vaarwater J, van den Berg M, de Klein A, Verdijk RM.

Invest Ophthalmol Vis Sci. 2013 Nov 8;54(12):7354-61. doi: 10.1167/iovs.13-12407.

PMID:
24052640
16.

Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis.

van den Bosch T, van Beek JG, Vaarwater J, Verdijk RM, Naus NC, Paridaens D, de Klein A, Kiliç E.

Invest Ophthalmol Vis Sci. 2012 May 14;53(6):2668-74. doi: 10.1167/iovs.11-8697.

PMID:
22427574
17.

Multiplex ligation-dependent probe amplification equals fluorescence in-situ hybridization for the identification of patients at risk for metastatic disease in uveal melanoma.

Vaarwater J, van den Bosch T, Mensink HW, van Kempen C, Verdijk RM, Naus NC, Paridaens D, Brüggenwirth HT, Kiliç E, de Klein A.

Melanoma Res. 2012 Feb;22(1):30-7. doi: 10.1097/CMR.0b013e32834e6a67.

PMID:
22157614
18.

Chromosome 3 intratumor heterogeneity in uveal melanoma.

Mensink HW, Vaarwater J, Kiliç E, Naus NC, Mooy N, Luyten G, Brüggenwirth HT, Paridaens D, de Klein A.

Invest Ophthalmol Vis Sci. 2009 Feb;50(2):500-4. doi: 10.1167/iovs.08-2279. Epub 2008 Sep 29.

PMID:
18824727
19.

Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome.

Mensink HW, Kiliç E, Vaarwater J, Douben H, Paridaens D, de Klein A.

Cancer Genet Cytogenet. 2008 Mar;181(2):108-11. doi: 10.1016/j.cancergencyto.2007.12.001.

PMID:
18295662
20.

Regional deletion and amplification on chromosome 6 in a uveal melanoma case without abnormalities on chromosomes 1p, 3 and 8.

van Gils W, Kilic E, Brüggenwirth HT, Vaarwater J, Verbiest MM, Beverloo B, van Til-Berg ME, Paridaens D, Luyten GP, de Klein A.

Melanoma Res. 2008 Feb;18(1):10-5. doi: 10.1097/CMR.0b013e3282f1d4d9.

PMID:
18227702

Supplemental Content

Loading ...
Support Center